Buprenorphine Tablets Recall: American Health Packaging 1030023
Announced 2026-09-09 · FDA
The recall involves Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 tablets (3x10), Rx only, distributed nationwide by American Health Packaging. The recall is due to a labeling mix-up. The affected lot is 1030023 with expiration date 06/30/2027, and 10,953 cartons are involved.
| Brand | American Health Packaging |
|---|---|
| Product | Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11). |
| Reason | Labeling: Label Mix-up |
| Severity | low |
| Units affected | 10953 |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any Buprenorphine Sublingual Tablets from Lot 1030023.
- Contact your prescriber or pharmacist for guidance and possible replacement or return.
- If you have the recalled product, segregate it and follow disposal or return instructions provided by your pharmacist or local regulatory guidance.
How to identify the recalled item
| Lot / date codes | Lot # 1030023, Exp Date: 06/30/2027. |
|---|---|
| Lot / date codes | Lot # 1030023, Exp Date: 06/30/2027. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.